89 related articles for article (PubMed ID: 15604413)
1. Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues.
Gorzalka S; Vittori S; Volpini R; Cristalli G; von Kügelgen I; Müller CE
Mol Pharmacol; 2005 Mar; 67(3):955-64. PubMed ID: 15604413
[TBL] [Abstract][Full Text] [Related]
2. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
3. Cloning and functional expression of a novel Gi protein-coupled receptor for adenine from mouse brain.
von Kügelgen I; Schiedel AC; Hoffmann K; Alsdorf BB; Abdelrahman A; Müller CE
Mol Pharmacol; 2008 Feb; 73(2):469-77. PubMed ID: 17975009
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
Evans T; Smith MM; Tanner LI; Harden TK
Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
[TBL] [Abstract][Full Text] [Related]
5. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific [3H]adenine-binding sites in rat brain membranes.
Watanabe S; Ikekita M; Nakata H
J Biochem; 2005 Mar; 137(3):323-9. PubMed ID: 15809333
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
Borrmann T; Abdelrahman A; Volpini R; Lambertucci C; Alksnis E; Gorzalka S; Knospe M; Schiedel AC; Cristalli G; Müller CE
J Med Chem; 2009 Oct; 52(19):5974-89. PubMed ID: 19731917
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the human P2Y13 receptor.
Marteau F; Le Poul E; Communi D; Communi D; Labouret C; Savi P; Boeynaems JM; Gonzalez NS
Mol Pharmacol; 2003 Jul; 64(1):104-12. PubMed ID: 12815166
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
11. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
12. Isolation of plasma membrane compartments from rat brain cortex; detection of agonist-stimulated G protein activity.
Bourova L; Stohr J; Lisy V; Rudajev V; Novotny J; Svoboda P
Med Sci Monit; 2009 Apr; 15(4):BR111-22. PubMed ID: 19333192
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins.
Dautzenberg FM
Biochem Pharmacol; 2005 May; 69(10):1493-9. PubMed ID: 15857613
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression and desensitization of adenosine A1 receptor/adenylyl cyclase pathway after chronic (-)N6-phenylisopropyladenosine intake during pregnancy.
León DA; Castillo CA; Albasanz JL; Martín M
Neuroscience; 2009 Oct; 163(2):524-32. PubMed ID: 19559760
[TBL] [Abstract][Full Text] [Related]
17. Adenylate cyclases in two populations of membranes purified from neuroblastoma X glioma hybrid (NG 108-15) cells.
Sweat FW; Klee WA
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):565-78. PubMed ID: 4086676
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
19. Homologous down-regulation of histamine H3 receptors in rat striatal slices.
Garduño-Torres B; Arias-Montaño JA
Synapse; 2006 Aug; 60(2):165-71. PubMed ID: 16715497
[TBL] [Abstract][Full Text] [Related]
20. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
